Skip to main content

$0.003 -0.001 (-16.67%)

High

$0.00

Low

$0.00

Trades

1

Turnover

$54

Volume

21,427
30 June 2023 at 2:30pm
Register to track ADR and receive email alerts.
Subject
ADR Ann: Becoming a substantial holder

ADR Ann: Cleansing notice under s708A of the Corporations Act

ADR Ann: Notification regarding unquoted securities - ADR

ADR Ann: Ceasing to be a substantial holder

ADR Ann: Notification of cessation of securities - ADR

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ADR Ann: Results of Meeting

ADR Ann: CEO Presentation to EGM

ADR Ann: ADR to present at Australian Microcap Investment Conference

ADR Ann: Notice Required under ASX Listing Rule 3.13.1

ADR Ann: Notification of cessation of securities - ADR

ADR Ann: Change in substantial holding

ADR Ann: Change in substantial holding

ADR Ann: Annual Report to shareholders

ADR Ann: Corporate Governance Statement 2022

ADR Ann: Appendix 4G

ADR Ann: Becoming a substantial holder

ADR Ann: Change in substantial holding

ADR Ann: Cleansing notice under s708A of the Corporations Act

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Notice of Extraordinary General Meeting/Proxy Form

ADR Ann: Adherium appoints Daniel Kaplon as Chief Financial Officer

ADR Ann: New Hailie sensors to be used in US clinical study

ADR Ann: Proposed issue of securities - ADR

ADR Ann: Proposed issue of securities - ADR

ADR Ann: Proposed issue of securities - ADR

ADR Ann: Proposed issue of securities - ADR

ADR Ann: Proposed issue of securities - ADR

ADR Ann: Proposed issue of securities - ADR

ADR Ann: Proposed issue of securities - ADR

ADR Ann: Adherium secures $13.5m in placement commitments

ADR Ann: Trading Halt

ADR Ann: Adherium to integrate Hailie into CareCentra AI platform

ADR Ann: Adherium and Dulcian Health patient monitoring integration

ADR Ann: Preliminary Final Report

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Adherium submits US FDA application for Hailie for Teva MDIs

ADR Ann: Adherium to present at Reach Markets webinar

ADR Ann: Adherium Investor Update Presentation August 2022

ADR Ann: Details of Company Address - Principal Administrative Office

ADR Ann: Adherium submits US FDA application for Hailie for GSK pMDIs

ADR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ADR Ann: Adherium receives US FDA clearance for Hailie for Ellipta

ADR Ann: Adherium signs US distribution agreement with Perigon Health

ADR Ann: Adherium signs UK distribution agreement with Helicon Health

ADR Ann: Adherium to support Avillion sponsored clinical study

ADR Ann: Adherium Senior Management Update

ADR Ann: Adherium Exhibiting at ATS 2022

ADR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

Register to track ADR and receive email alerts.

Similar Companies

VHT